menopause and glp 1 Weight Gain During Menopause: Solutions in the Era of GLP1-agonists GLP-1 for Menopause Weight Loss

Your provider will likely start you on a low dose and gradually increase it to help minimize these effects

J J Wurtman

Poly (glutamic acid): Production, composites, and medical applications of the next-generation biopolymer

Consider your practical constraints

GIP Receptor Adipose Obesity Rev 2021 View on PubMed 2022 Journal of Hepatology NAFLD GLP-3 (Triple Agonist) Reduces Visceral Adiposity and Liver Steatosis Synergistically Finding: In high-fat diet obese rodent models, a GLP-1/GIP/glucagon triple agonist reduced visceral adipose tissue by 35% (vs 18% GLP-1 alone) and hepatic lipid content by 51% (vs 28% GLP-1 alone)

Numerous others offer the benefits of Glutathione and other antioxidants outside of the heart